The use of venetoclax (ABT-199) in the treatment of CLL
Changes in research to overcome the problem of resistance to new CLL drugs
Brewing T-cell therapies for leukemia and lymphoma
Prognostic markers for CLL - how do they help determine who gets which treatment?
Side effects of idelalisib in CLL and how to manage them